Here are the Medicare Part D drugs expected to face 2025 price negotiations
With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, ...
Jim Cramer on The Home Depot Inc. (HD): ‘We Like Home Depot’s Exposure To Professional Customers’
We recently compiled a list of the Cramer’s Morning Thoughts: 20 Stocks to Watch. In this article, we are going to take a ...
BioPharma Dive17h
Approval in hand, Bristol Myers sets out to sell first-of-its-kind schizophrenia drug
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer
AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated ...
ETJ: Antitrust Lawsuits Could Drag On The Fund's Portfolio
Investors seeking high income with downside protection may consider the Eaton Vance Risk-Managed Diversified Equity Income ...